FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053722761> ?p ?o ?g. }

• W2053722761 endingPage "565" @default.
• W2053722761 startingPage "561" @default.
• W2053722761 abstract "Injecting drug use, mainly of heroin, currently represents a major public health issue in the North East of Scotland. The recent tendency of the committed injecting drug user to inject into the groin has created novel problems for the Infection Unit. Data are presented on 20 consecutive patients admitted between 1994 and 1999 with iliofemoral venous thromboses, often complicated by severe soft tissue infections and bacteraemia as a result of heroin injection into the femoral vein. Nine had coexistent groin abscesses, four had severe streptococcal soft tissue infection of the right thigh, groin and lower abdomen, and two had coincidental soft tissue infections of the upper limb. Nine were bacteraemic on admission. All of the patients were chronic injecting drug users with a median injection duration of 6.5 years. The 18 patients tested for hepatitis C virus were all seropositive. None of the 14 patients tested was positive for HIV. Seventeen patients were treated with subcutaneous low molecular weight heparin (tinzaparin), three having received intravenous unfractionated heparin initially. The tinzaparin was self administered and given for a median duration of seven weeks. One patient declined to have any treatment. Three months after presentation eight patients were asymptomatic, seven had a persistently swollen leg, and five were lost to follow up. None developed clinically apparent pulmonary embolism after institution of anticoagulant therapy. The management of iliofemoral venous thrombosis in injection drug users is problematic because of poor venous access, non-compliance with prescribed treatment, ongoing injecting behaviour, and coexistent sepsis. It is unlikely that a randomised trial of standard treatment with heparin and warfarin versus low molecular weight heparin alone would be practical in this patient group. These retrospective data indicate that the use of tinzaparin in injecting drug users is feasible and appears to result in satisfactory clinical responses. The possibility of concomitant infection in injecting drug users with venous thrombosis should always be addressed, as it appears to be a common phenomenon. Early drainage of abscesses and antimicrobial chemotherapy, often administered intramuscularly or orally because of lack of peripheral venous access, is central to the appropriate care of these patients." @default.
• W2053722761 created "2016-06-24" @default.
• W2053722761 creator A5000760060 @default.
• W2053722761 creator A5024295607 @default.
• W2053722761 creator A5056535670 @default.
• W2053722761 creator A5061526380 @default.
• W2053722761 creator A5070707354 @default.
• W2053722761 date "2000-09-01" @default.
• W2053722761 modified "2023-10-05" @default.
• W2053722761 title "High prevalence of iliofemoral venous thrombosis with severe groin infection among injecting drug users in North East Scotland: successful use of low molecular weight heparin with antibiotics" @default.
• W2053722761 cites W1844118350 @default.
• W2053722761 cites W1963580622 @default.
• W2053722761 cites W1982999510 @default.
• W2053722761 cites W1985639992 @default.
• W2053722761 cites W1995396807 @default.
• W2053722761 cites W2007112882 @default.
• W2053722761 cites W2017548084 @default.
• W2053722761 cites W2074994142 @default.
• W2053722761 cites W2075196907 @default.
• W2053722761 cites W2081837424 @default.
• W2053722761 cites W2126864773 @default.
• W2053722761 cites W2128973544 @default.
• W2053722761 cites W2137897164 @default.
• W2053722761 cites W2167269024 @default.
• W2053722761 cites W2312814626 @default.
• W2053722761 cites W2333983635 @default.
• W2053722761 cites W2412573214 @default.
• W2053722761 cites W2413619587 @default.
• W2053722761 cites W2438200059 @default.
• W2053722761 cites W2443272095 @default.
• W2053722761 cites W4290171191 @default.
• W2053722761 doi "https://doi.org/10.1136/pmj.76.899.561" @default.
• W2053722761 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1741719" @default.
• W2053722761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10964121" @default.
• W2053722761 hasPublicationYear "2000" @default.
• W2053722761 type Work @default.
• W2053722761 sameAs 2053722761 @default.
• W2053722761 citedByCount "68" @default.
• W2053722761 countsByYear W20537227612012 @default.
• W2053722761 countsByYear W20537227612013 @default.
• W2053722761 countsByYear W20537227612014 @default.
• W2053722761 countsByYear W20537227612015 @default.
• W2053722761 countsByYear W20537227612016 @default.
• W2053722761 countsByYear W20537227612017 @default.
• W2053722761 countsByYear W20537227612018 @default.
• W2053722761 countsByYear W20537227612019 @default.
• W2053722761 countsByYear W20537227612020 @default.
• W2053722761 countsByYear W20537227612021 @default.
• W2053722761 countsByYear W20537227612022 @default.
• W2053722761 countsByYear W20537227612023 @default.
• W2053722761 crossrefType "journal-article" @default.
• W2053722761 hasAuthorship W2053722761A5000760060 @default.
• W2053722761 hasAuthorship W2053722761A5024295607 @default.
• W2053722761 hasAuthorship W2053722761A5056535670 @default.
• W2053722761 hasAuthorship W2053722761A5061526380 @default.
• W2053722761 hasAuthorship W2053722761A5070707354 @default.
• W2053722761 hasBestOaLocation W20537227611 @default.
• W2053722761 hasConcept C141071460 @default.
• W2053722761 hasConcept C2776265017 @default.
• W2053722761 hasConcept C2776884760 @default.
• W2053722761 hasConcept C2777557582 @default.
• W2053722761 hasConcept C2777910003 @default.
• W2053722761 hasConcept C2778384902 @default.
• W2053722761 hasConcept C2779075128 @default.
• W2053722761 hasConcept C2779967601 @default.
• W2053722761 hasConcept C2780011451 @default.
• W2053722761 hasConcept C2780868729 @default.
• W2053722761 hasConcept C71924100 @default.
• W2053722761 hasConceptScore W2053722761C141071460 @default.
• W2053722761 hasConceptScore W2053722761C2776265017 @default.
• W2053722761 hasConceptScore W2053722761C2776884760 @default.
• W2053722761 hasConceptScore W2053722761C2777557582 @default.
• W2053722761 hasConceptScore W2053722761C2777910003 @default.
• W2053722761 hasConceptScore W2053722761C2778384902 @default.
• W2053722761 hasConceptScore W2053722761C2779075128 @default.
• W2053722761 hasConceptScore W2053722761C2779967601 @default.
• W2053722761 hasConceptScore W2053722761C2780011451 @default.
• W2053722761 hasConceptScore W2053722761C2780868729 @default.
• W2053722761 hasConceptScore W2053722761C71924100 @default.
• W2053722761 hasIssue "899" @default.
• W2053722761 hasLocation W20537227611 @default.
• W2053722761 hasLocation W20537227612 @default.
• W2053722761 hasLocation W20537227613 @default.
• W2053722761 hasLocation W20537227614 @default.
• W2053722761 hasLocation W20537227615 @default.
• W2053722761 hasOpenAccess W2053722761 @default.
• W2053722761 hasPrimaryLocation W20537227611 @default.
• W2053722761 hasRelatedWork W1990111999 @default.
• W2053722761 hasRelatedWork W2085296783 @default.
• W2053722761 hasRelatedWork W220073818 @default.
• W2053722761 hasRelatedWork W2339501367 @default.
• W2053722761 hasRelatedWork W2407594508 @default.
• W2053722761 hasRelatedWork W2413633207 @default.
• W2053722761 hasRelatedWork W2418367129 @default.
• W2053722761 hasRelatedWork W2432913978 @default.
• W2053722761 hasRelatedWork W2464810639 @default.
• W2053722761 hasRelatedWork W4231905262 @default.
• W2053722761 hasVolume "76" @default.

• next